Cardiovascular Drug Reviews

Title Publication Date Language Citations
Cardiovascular Protective Effects of Resveratrol2004/09/01English371
The Many Faces of H89: A Review2006/09/01English242
Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodilator Effects2002/09/01English236
Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP Inhibitors2007/09/01English223
C‐Reactive Protein (CRP)‐Lowering Agents2006/03/01English189
Prasugrel: A Novel Thienopyridine Antiplatelet Agent. A Review of Preclinical and Clinical Studies and the Mechanistic Basis for Its Distinct Antiplatelet Profile2007/12/01English174
Cardiovascular Actions of Berberine2001/09/01English168
A Review on Telmisartan: A Novel, Long‐Acting Angiotensin II‐Receptor Antagonist2000/06/01English157
Therapeutic Use of Citrulline in Cardiovascular Disease2006/09/01English150
Cilostazol (Pletal®): A Dual Inhibitor of Cyclic Nucleotide Phosphodiesterase Type 3 and Adenosine Uptake2001/12/01English142
Rosuvastatin: A Highly Effective New HMG‐CoA Reductase Inhibitor2002/12/01English138
Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent1993/06/01English132
Perhexiline2007/03/01English126
Pharmacological Actions of Sodium Ferulate in Cardiovascular System2006/06/07English119
Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents — The Selective Factor Xa Inhibitors2002/03/01English105
Antiatherogenic Properties of Naringenin, a Citrus Flavonoid1999/06/01English104
Basic Experimental Studies and Clinical Aspects of Gadolinium Salts and Chelates2001/03/01English94
Carvedilol: Molecular and Cellular Basis for Its Multifaceted Therapeutic Potential2001/06/01English91
Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG‐CoA Reductase Inhibitor2003/09/01English90
Tolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical Trials2007/03/01English84
Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist1995/09/01English83
Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA)2001/09/01English80
Trimetazidine, A Cellular Anti‐ischemic Agent1988/12/01English77
Pharmacological Mechanisms Contributing to the Clinical Efficacy of Levosimendan2005/03/01English77
Oxidative Stress as the Leading Cause of Acute Myocardial Infarction in Diabetics2006/06/01English76
Angiotensin‐(1‐7): Pharmacology and New Perspectives in Cardiovascular Treatments2007/06/01English75
Role of Adenosine as Adjunctive Therapy in Acute Myocardial Infarction2006/06/01English72
Cardiovascular Therapeutic Aspects of Soluble Epoxide Hydrolase Inhibitors2006/06/01English72
L‐Dihydroxyphenylserine (L‐DOPS): A Norepinephrine Prodrug2006/09/01English72
Ro 40–5967: A New Nondihydropyridine Calcium Antagonist1991/03/01English71